Hospital-based use of thromboprophylaxis in patients with COVID-19

Lancet. 2020 May 2;395(10234):e75. doi: 10.1016/S0140-6736(20)30926-0. Epub 2020 Apr 21.

Authors

Alex C Spyropoulos¹, Walter Ageno², Elliot S Barnathan³

Affiliations

¹ Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Center for Health Innovation and Outcomes Research, Feinstein Institutes for Medical Research, Department of Medicine, Northwell Health at Lenox Hill Hospital, New York City, 10577 NY, USA. Electronic address: [email protected].
² Department of Medicine and Surgery, University of Insubria, Varese, Italy.
³ Janssen Research and Development, Spring House, PA, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Betacoronavirus
COVID-19
Coronavirus Infections
Coronavirus*
Humans
Pandemics
Pneumonia, Viral
Prognosis
SARS-CoV-2
Venous Thromboembolism*

Substances

Anticoagulants